The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on September 3, 2026

Sep. 3, 2026

TÜV Rheinland and BG Networks announce strategic partnership to accelerate product cybersecurity compliance

Indeterminate EIN Presswire

Sep. 3, 2026

MASSACHUSETTS EARNS 49 MEDALS AT SKILLSUSA CHAMPIONSHIPS

Indeterminate EIN Presswire

Sep. 3, 2026

Independent Study quantified 474% ROI from Huwise data product marketplace

Indeterminate EIN Presswire

Sep. 3, 2026

Securityplus FCU Embraces Agentic CRM to Deliver More Connected Member Experiences

Indeterminate EIN Presswire

Sep. 3, 2026

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Indeterminate GlobeNewswire

Sep. 3, 2026

Data Shows Modern Pests’ SMART Rodent Control Prevented Millions of Rats in Somerville, Quincy, and Greater Boston

Indeterminate EIN Presswire

Sep. 3, 2026

Sophos To Bring OpenAI GPT Cyber Models Into Managed Risk Offering, Helping Defenders Validate Exploit Paths

Indeterminate GlobeNewswire

Sep. 3, 2026

Immuneering to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Spyre Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 3, 2026

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 3, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 3, 2026

Alkeus Announces Publication in JAMA Ophthalmology of Efficacy and Safety Results from the TEASE-1 Study of Gildeuretinol in Stargardt Disease

Indeterminate GlobeNewswire

Sep. 3, 2026

Solo.io Extends Agentic Governance to the Desktop with agentdesktop

Indeterminate GlobeNewswire

Sep. 3, 2026

Lumafield Introduces Quality Agent, a Physical AI Technology that Automates Defect Detection and Root-Cause Analysis for Manufacturers

Indeterminate GlobeNewswire

Sep. 3, 2026

CarGurus Appoints Matthew Mandel as Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 3, 2026

Rapid7 to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 3, 2026

Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire